Skip to main content
Equibles

US BANCORP \DE\

Bank

Position in LYEL — Lyell Immunopharma, Inc.

CIK 36104 MINNEAPOLIS, MN
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$814
-$349 QoQ
Shares Held
58
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 87 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $83,094,208 across 214 Biotechnology names. LYEL ranks #191 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 66,580 $16,296,786
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 32,020 $15,905,293
3 TECH
BIO-TECHNE Corp
 137,966 $9,747,297
4 REGN
Regeneron Pharmaceuticals, Inc.
 5,330 $3,323,466
5 ARGX
Argenx SE
 3,495 $3,242,555
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 38,226 $3,115,799
7 JAZZ
Jazz Pharmaceuticals plc
 10,103 $2,434,518
8 GMAB
Genmab A/S
 88,420 $2,428,896

All Filings in LYEL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $814 58
2026-03-31 $1,163 58
2025-12-31 $1,785 58
2025-09-30 $941 58
2025-06-30 $512 58
2025-03-31 $626 1,165
2024-12-31 $745 1,165
2024-09-30 $1,607 1,165
2024-06-30 $1,689 1,165
2024-03-31 $2,597 1,165
2023-09-30 $3,470 2,361
2023-06-30 $7,507 2,361
2023-03-31 $1,963 832
2022-12-31 $2,599 749